Area of research
Pulmonary and Respiratory Medicine · Statistics and Probability
Research interest
Research interests include Renal cell carcinoma treatment, Statistical Methods in Clinical Trials, Cancer Immunotherapy and Biomarkers, and Bladder and Urothelial Cancer Treatments.
Overall Survival and Quality-of-Life Superiority in Modern Phase 3 Oncology Trials
Treatment‐Related Adverse Events and Associated Outcomes in Patients With Advanced Urothelial Carcinoma Treated With Enfortumab Vedotin: Analysis of the <scp>UNITE</scp> Study
Immune Checkpoint Therapy Combinations in Adult Advanced MiT Family Translocation Renal Cell Carcinomas
Prevalence and implications of significance testing for baseline covariate imbalance in randomised cancer clinical trials: The Table 1 Fallacy
Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression
Efficacy of Cabozantinib in Metastatic MiT Family Translocation Renal Cell Carcinomas
Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomes
Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary Carcinoma
p53 Is a Master Regulator of Proteostasis in SMARCB1-Deficient Malignant Rhabdoid Tumors
Cabozantinib for the treatment of patients with metastatic non-clear cell renal cell carcinoma: A retrospective analysis
Accuracy of Conventional Transthoracic Echocardiography for the Diagnosis of Intracardiac Right‐to‐Left Shunt: A Meta‐Analysis of Prospective Studies
Research update for articles published in EJCI in 2012